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Meniscal tears are the most common knee injuries and have a poor ability of healing. In the last few decades, several techniques
have been increasingly used to optimize meniscal healing. Current research eﬀorts of tissue engineering try to combine cell-based
therapy, growth factors, gene therapy, and reabsorbable scaﬀolds to promote healing of meniscal defects. Preliminary studies did
notallowto draw deﬁnitive conclusionson the useofthese techniques forroutine managementofmeniscallesions.Weperformed
a review of the available literature on current techniques of tissue engineering for the management of meniscal tears.
1.Introduction
The menisci of the knee are two ﬁbrocartilaginous C-
shaped discs interposed between the femoral and tibial joint
surfaces. They provide shock absorption, stabilization, lubri-
cation, load distribution, and joint ﬁller supplying femoral-
tibial incongruity [1, 2]. Traumatic lesions of the menisci are
common and induce changes in biomechanical behaviour of
the joint aﬀecting the load distribution and contact stresses
[3]. The healing process of torn menisci depends on their
morphologic features. Each meniscus consists of outer vas-
cular part and inner avascular part. The vascular supply is an
importantfactortodeterminethepotentialhealingofmenis-
cal tears [4]. Therefore, lesions of the outer one-third of the
meniscus are believed to have the greatest capacity for repair.
Meniscal tears are usually located in the inner avascular part
of the meniscus and are not able to heal spontaneously.
Several strategies to repair and replace meniscus have been
proposed, but only few of them have been shown to be ef-
fective [5–9].
Depending on the type of lesion, surgical approaches
include total or subtotal meniscectomy, transplantation, and
repair [10]. As the ﬁbrocartilaginous tissue of the meniscus
presents a limited regenerative capacity, new approaches are
requiredtoimprovemeniscalhealing.Inthelastfewdecades,
several emerging strategies, including growth factors, gene
therapy, and application of mesenchymal stem cells (MSCs),
have been proposed to increase healing of a damaged menis-
cus by tissue-engineered constructs. Tissue engineering is
based onacombinationofcells, growthfactors, and scaﬀolds
able to stimulate the meniscal healing [11, 12].
We performed a review of the available literature on cur-
rent techniques of tissue engineering for the management of
meniscal tears.
2.CellsTransplantation
Human menisci are populated by diﬀerent cell types that
might respond diﬀerently to various stimuli released from2 Stem Cells International
the matrix [13, 14]. Cell-based therapy has signiﬁcantly con-
tributed to develop tissue-engineering strategies consisting
of cells-scaﬀold constructs able to promote healing in an
avascular environment [15]. Autologous ﬁbrochondrocytes
are one of the cell types used in meniscal repair. Fibrochon-
drocytesare abletoproliferateandproducenew extracellular
matrix (ECM) [16]. The amount of glycosaminoglycans
(GAGs) produced by ﬁbrochondrocytes from the inner avas-
cular part is more than the amount produced from a periph-
eral ﬁbrous location when seeded into a porous collagen
scaﬀold [17, 18]. Although these ﬁndings are encouraging,
the application of autologous ﬁbrochondrocytes in meniscal
tissue engineering is limited by the diﬃculty to harvest a
suﬃcient number of cells.
A na l t e r n a t i v ec e l lt y p eu s e dt op r o m o t et h eh e a l i n go f
meniscal lesions is the articular chondrocyte [19, 20]. Peretti
et al. [19] described a porcine chondrocyte model where
implantation of such cells was performed in the avascular
part of the meniscus, using an allogenic scaﬀold seeded with
autologous chondrocytes, showing that these chondrocytes
were able to heal a meniscal tear [19]. Another potential cell
therapy approach is represented by MSCs. These pluripotent
cells are able to diﬀerentiate into speciﬁc therapeutic cell
types (developmental plasticity) [21–23].
The eﬀects of extrinsic stimuli (biochemical, physical,
and mechanical) from the microenvironment, within a cell/
scaﬀold combination, are a promising alternative for repair-
ing large meniscal defects [24]. Several studies conﬁrm pro-
duction of abundant extracellular matrix around the cells,
restoringameniscal-liketissueintheavascularzone[25–28].
In particular, the combination of growth factors and mes-
enchymal stem cells within scaﬀold implants increased pro-
teoglycan and/or collagen synthesis [26, 28, 29].
The eﬀectofload onall these diﬀerentcell typesbecomes
an interesting ﬁeld for future research. Moreover, their stim-
ulation with the application of growth factors in combina-
tionwith a mechanically loadablescaﬀoldhasbeenproposed
as the focus of future studies.
3.GrowthFactors
Growth factors typically act on target cells as signalling mol-
ecules, promoting cell diﬀerentiation and chondrocytic pro-
liferation [30]. They also stimulate the synthesis and inhibit
degradation of (extracellular matrix) ECM by a mechanism
of downregulation of proteases [31]. Several growth factors
have been demonstrated to have an eﬀect on the healing of
tears and on ECM synthesis in tissue and cell culture. In par-
ticular, transforming growth factor-β1( T G F - β1) seems to
have several regulatory activities to stimulate the production
of extracellular matrix and collagen type II by meniscus cells
[30, 32]. Application of this growth factor has resulted in the
synthesis of speciﬁc proteoglycans to enhance both collagen
and GAGs production and their biomechanical properties
[33,34].PangbornandAthanasiou[35]us edT GF -β1t oha v e
consistent eﬀects on collagen and proteoglycan production
by meniscal cells. TGF-β1 was applied to monolayer cultures
for3weeksandgenerallyshowedahigherproductionofeach
ECM component.
Fibroblast growth factor-2 (FGF-2) is another important
factor found in the cartilaginous matrix. It enhances prolif-
eration of the joint chondrocytes, mesenchymal stem cells,
osteoblast, and adipocytes. In addition, FGF can also main-
tain the ability of any cell types to diﬀerentiate [36, 37].
Recently, FGF-2 has been vectored with recombinant ade-
noassociated virus (rAAV) [38]. Histology demonstrated en-
hanced cell proliferation and expression of the α-smooth
muscle actin (α-SMA) contractile marker, but it did not sig-
niﬁcantly enhancethesynthesis ofmajorextracellularmatrix
components or DNA contents.
Otherauthors haveidentiﬁedbasic ﬁbroblastgrowthfac-
tor (bFGF) as eﬀective at stimulating extracellular matrix
production in cell and tissue development. The ovine exper-
imental model showed the presence of meniscal ﬁbrochon-
drocytes responding to bFGF by proliferating and producing




collagen II, and integrins. In a recent study, the eﬀects of
three growth factors regimens was examined: basic ﬁbroblast
growthfactor (bFGF)alone, bFGF plustransforming growth
factor (TGF-β1), and IGF-1 [41]. The mixture ofgrowthfac-
tors showed an upregulation of collagen II and aggrecans
undertheeﬀectsofTGF-β1andIGF -1thatma ybeanimpor -
tant cellular response to mediate avascular meniscal healing.
The induction of angiogenesis is an important factor to
stimulate the poor potential healing of meniscal tears. The
vascular endothelial growth factor (VEGF) may promote
better healing, stimulating angiogenesis to improve the heal-
ing capacities of meniscus tissue. However, a study by
Petersenetal.didnotleadtosatisfactory results,andthelocal
application of VEGF didnot promote meniscus healing [42].
Bone morphogenetic proteins (BMPs) are members of
the TGF-β superfamily and play an important role during
embryogenesis and tissue repair by their osteoinductive pro-
perties [43, 44] .B M P - 2a c t sa sas t i m u l u si nt h ed i ﬀerentia-
tion of mesenchymal cell. It also presents a migratory eﬀect
in endothelial cells or smooth muscle cells, but rarely in cho-
ndrocytes. Alternatively, BMP-7 can have a function in reg-
ulating matrix homeostasi and can inhibit the degradation
processes. BMP-7 acts with diﬀerent chondrogenic agents
and is more eﬀective than BMP-2 for chondrogenic diﬀeren-
tiation of MSCs [45]. Minehara et al. [46] developed a new
technique for seeding chondrocytes onto solvent-preserved
human meniscus using the chemokinetic eﬀect of recom-
binant human bone morphogenetic protein-2 (rhBMP-2)
on chondrocytes seeded into solvent-preserved human men-
iscus. After a 3-week incubation, a natural chemokinetic ef-
fect of rhBMP-2 promoted migration and proliferation of
chondrocytes. These ﬁndings demonstrate that BMPs induce
a marked cellular response to improve meniscal repair.
4.PreparationsRichinGrowthFactors
The application of growth factors has been proven to be ef-
fective for meniscal healing. Recently, platelet-rich plasmaStem Cells International 3
(PRP) may be better than the use of isolated growth factors.
PRP is an autologous substance rich in platelets. It is easily
prepared by spinning autologous blood in a centrifuge to
form a dense ﬁbrin matrix that can be placed directly at the
meniscal repair site [47, 48]. Ishida et al. reported the regen-
erative eﬀects of platelet-rich plasma in a rabbit model [49].
Cultured meniscal cells were prepared to assess proliferative
pattern under the exposure to PRP. Histological ﬁndings
showed the healing properties of PRP in extracellular matrix
synthesis and cell proliferation.
5.BiomaterialUsed inTissueEngineering
Tissue engineering techniques using novel scaﬀold materials
oﬀer potential alternatives for managing meniscal tears. An
idealscaﬀoldshouldhavethebasicstructureofthemeniscus,
and it should be biodegradable and bio-reabsorbable in
the long term. Probably, the most important functions
are the induction of cell proliferation and production of
extracellular matrix, using it as a carrier for stimulatory and
inhibitory growth. The structure should be strong enough to
withstand the load in the joint and maintain its structural
integrity without damaging the articular cartilage [15, 31,
50–52].
Several materials used to fabricate scaﬀolds (natural or
synthetic) may be considered for application in tissue engi-
neering of the meniscal healing. The ﬁrst to be developedare
natural scaﬀolds as periosteal tissue, perichondral tissue, col-
lagen, small intestine submucosa, silk, and meniscus tissue
itself [53].
A multilayered (tribiological), multiporous silk scaﬀold
system to mimic native meniscus architecture and shape was
described[54].Silkconstructsshowedagoodbiocompatibil-
ity with a ﬂorid chondrogenesis as well as other tissues [54–
57]. The cells (human articular chondrocytes and dermal
ﬁbroblast cells) were seeded onto the silk scaﬀold in asso-
ciation with human chondrocytes for 28 days. Histological
analysis showed an increase production of GAGs and pro-
teoglycansand a colonization ofECM similar to native tissue
from ﬁbroblasts and chondrocytes.
Minehara et al. developed a cell-seeding technique using
a solvent-preserved human meniscus as a scaﬀold [46]. The
chondral cells were treated with recombinant human bone
morphogenetic protein-2 (rhBMP-2) and cultured for 3
weeks. The histological and immunohistochemical analyses
indicated that this repair tissue was mainly ﬁbrous. More-
over, results suggest a potential application of rhBMP-2
as a natural chemokinetic factor into a scaﬀold for tissue
engineering.
Collagen scaﬀolds have been also examined for tissue en-
gineering of the meniscus. Meniscus cells seeded in these
scaﬀolds may express alpha-smooth muscle actin (α-SMA)
that has contractile capacities. This demonstrates the poten-
tial healing in wound contraction, but other physiological
and pathological processes are still unknown [58, 59]. Muel-
ler et al. studied collagen type I and II scaﬀolds seeded with
canine ﬁbrochondrocytes for 21 days [60]. Type II scaﬀold
containedupto50% moreGAGs than typeIscaﬀold.Alimit
of the collagen scaﬀolds may be their poor mechanical prop-
erties, as the shape of the construct cannot be varied.
The use of synthetic polymer-based scaﬀolds is a novel
option oﬀering the potential of earlier healing. Stewart et al.
[61]usedpolyglycolicacid(PGA)scaﬀoldsseededwithovine
meniscal chondrocytes. The cells were seeded onto the PGA
scaﬀold in the presence of platelet-derived growth factor-
(PDGF-) AB, PDGF-BB, insulin-like growth factor- (IGF-)
I, transforming growth factor-beta1 (TGF-β1), and basic ﬁ-
broblast growth factor (bFGF) and evaluated after 39 days.
Histological analysis of sections from ovine meniscal chon-
drocytes PGA scaﬀolds did not show any diﬀerence in GAG
or collagen production between the treatment groups. How-
ever, immunohistochemical analysis demonstrated a dif-
ferent expression of collagen production: the production of
collagen type I was increased, whereas the collagen type II
was decrease at day 39 in all constructs functionalized with
growth factors. A concomitant high inﬁltration of cells was
also found.
Another tissue-engineered strategy consists in a poly-L-
lactic acid (PLLA) scaﬀold used in association with culture
of meniscus cells and bFGF under hypoxic conditions [62].
After4 weeks, histologicalevaluationdemonstrated thepres-
ence of collagen and GAG, probably due to synergic eﬀects
of hypoxia and bFGF. An earlier study by Ionescu tested
the eﬀects of TGF-β1 as a function of age, on proliferation
of bovine meniscus ﬁbrochondrocytes (MFCs) in a poly-
caprolactone (PCL) cylindrical scaﬀold [63]. Even though
the results indicated a loss of proliferation and migration
capacity with aging, the addition of TGF-b showed better
maintenance of overall explant properties.
6.Gene Therapy
Gene therapy is considered an alternative strategy to develop
future protocols for tissue engineering of meniscus tissue,
usingviralornonviralvectorsordirectgenetransfer[64,65].
In this way, the transfer of genes used to encode healing
factors is a valid technique to apply growth factors to the site
of injury for extended period. The vectors most frequently
used in meniscal lesion are adenovirus, adenoassociated
virus (AAV), and retrovirus. Nonviral vectors are not indi-
cated because of being less eﬃcient, although they are less
pathogenic. Viral vectors allow the insertion of genes into
death cells and the production of growth factors.
Previously, we mentioned a study where FGF-2 in asso-
ciation with recombinant adenoassociated virus (rAAV) vec-
tors were used [38].
Goto et al. [66] developed a gene therapy strategy based
on monolayer cultures of human and canine meniscal cells
infected with retroviruses carrying human TGF-β1c D N Ao r
marker genes. There was an increased synthesis of collagen
and proteoglycan in response to the addition of TGF-β1.
Another possible technique for gene transfection is the
injection of adenovirus vector encoding the hepatocyte
growthfactorgene(AdHGF)incell-seededbovinePGAscaf-
folds [67]. This strategy showed the formation of vascu-
larised ﬁbrous tissue by 2 weeks and vascularized meniscus-
like tissue in 8 weeks. The authors concluded that gene4 Stem Cells International
transfer techniques could be used to induce blood vessel
formation in tissue engineering meniscus samples.
7.Discussions
Application of tissue engineering is a promising alterna-
tive approach for the management of meniscus injuries.
Advances in meniscal tissue engineering focus on the use
of diﬀerent cell sources, scaﬀolds, growth factors, or a com-
bination thereof. The potential eﬀect of cell-based therapy
for meniscal tears could improve healing of lesion in the
avascular zone and expand the indication for repair rather
thanremoval.Avarietyofcelltypessuchasautologousﬁbro-
chondrocytes, articular chondrocytes, and MSCs are avail-
able in large quantities into the body and can be used in
tissueengineering[17–19,28].Ofthese,progenitorcellssuch
as mesenchymal stem cells have the advantage to be easily
expandable without the loss of their diﬀerentiation potential
into a variety of mesenchymal tissues [68–80] including
bone, tendon, cartilage, muscle, ligament, fat, and marrow
strom [13, 21, 22]. Probably, the application of MSCs might
be a better cell source than ﬁbrochondrocytes for meniscus
repair [81–94].
The long-term biochemical and biomechanical features
of tissue engineering techniques are determined by a com-
bination of a well-integrated cell population with a scaf-
fold. The development of carrier scaﬀolds should provide
mechanical stability of the meniscus, maintaining its struc-
tural integrity without damaging the articular cartilage [15,
51]. Several scaﬀold implants have been investigated in the
management of meniscal tears [93–109].
The use of growth factors has been demonstrated to have
an eﬀect on the healing of tears and on ECM synthesis in
tissueand cellculture[30,61].Directintroductionofgrowth
factors, such as TGF-β, BMPs, IGF-1, FGF, and VEGF, has
positively inﬂuenced the clinical outcome of the meniscal
repair procedures [33, 59, 110]. Previous studies have de-
monstrated that the eﬀects of TGF-β1a n dB M P sh a v ea
better potential to help healing in tissue engineering [34,
45, 46]. The focus in this future research should be on the
assessment of a mechanically loadable scaﬀold that retains
growth factors and at the same time is degraded to allow
revascularisation [111–128].
Alternatively, gene transfer techniques represent a favor-
able strategy for growth factor delivery, inducing vasculari-
sation of tissue-engineered constructs [66, 67, 110]. Several
viral vectors expressing therapeutic proteins such as growth
factors have been investigated to assess their potential to
improve remodelling and healing of meniscus. Although
gene therapy is a relatively new ﬁeld in tissue-engineered
menisci, it is one ofthe treatment optionsin thefuture [129–
140].
8.Conclusion
The importance of the meniscus in safeguarding joint func-
tion has gained a considerable interest in the recent years.
The current therapeutic strategy to treat meniscal defects is
partial or total meniscectomy, but this may predispose pa-
tients, especially younger individual, to early osteoarthritis
changes [11, 12, 141–152]. The management of meniscal
pathologytopromotea healingresponse isconsideredessen-
tial in dealing with these injuries [153–168]. When possi-
ble, meniscal repair should be performed to try to main-
tain meniscal integrity and prevent long-term degenerative
changes.
New therapeutic strategies of meniscal replacement and
tissue engineering need to be developed, but they are still at
their infancies [11, 12]. The ﬁrst step, the need to develop
autologous grafting procedure, consists in ﬁnding the best
cell source for meniscus repair, which to date seems to be the
MSCs. The second step consists in fabricating an opportune
biological scaﬀold which is able to carry cells into the menis-
cal lesion and to allow their diﬀerentiation, proliferation,
and ECM synthesis to produce a meniscal native-like tissue.
The biological activity of scaﬀold should be implemented
t h r o u g hi t sf u n c t i o n a l i z a t i o nw i t hg r o w t hf a c t o r s ,s u c ha s
TGF-β1a n dB M P s[ 169–199].
Further research is necessary to successfully address the
diﬃcult problemof meniscal regeneration. Advancementsin
this ﬁeld should be strongly encouraged, because of autol-
ogous grafting through either tissue engineering for repair
or that complete replacement following excision represents
a suitable alternative to partial or total meniscectomy or
cadaveric implants.
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